Stivarga (regorafenib)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) June 2016 WARNINGS AND PRECAUTIONS Hepatotoxicity Severe drug-induced liver injury with fatal outcome occurred in...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts